Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy

R Silva, V Vilas-Boas, H Carmo… - Pharmacology & …, 2015 - Elsevier
Abstract P-glycoprotein (P-gp) is an ATP-dependent efflux pump encoded by the MDR1
gene in humans, known to mediate multidrug resistance of neoplastic cells to cancer …

MYC and therapy resistance in cancer: risks and opportunities

G Donati, B Amati - Molecular oncology, 2022 - Wiley Online Library
The MYC transcription factor, encoded by the c‐MYC proto‐oncogene, is activated by
growth‐promoting signals, and is a key regulator of biosynthetic and metabolic pathways …

A tubular DNA nanodevice as a siRNA/chemo‐drug co‐delivery vehicle for combined cancer therapy

Z Wang, L Song, Q Liu, R Tian, Y Shang… - Angewandte …, 2021 - Wiley Online Library
Using the DNA origami technique, we constructed a DNA nanodevice functionalized with
small interfering RNA (siRNA) within its inner cavity and the chemotherapeutic drug …

Circumventing cancer drug resistance in the era of personalized medicine

LA Garraway, PA Jänne - Cancer discovery, 2012 - AACR
All successful cancer therapies are limited by the development of drug resistance. The
increase in the understanding of the molecular and biochemical bases of drug efficacy has …

Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties

G Galati, PJ O'brien - Free radical biology and medicine, 2004 - Elsevier
Flavonoids, including isoflavones, are natural components in our diet and, with the
burgeoning interest in alternative medicine, are increasingly being ingested by the general …

Multidrug resistance (MDR) in cancer: mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of …

R Krishna, LD Mayer - European journal of pharmaceutical sciences, 2000 - Elsevier
In recent years, there has been an increased understanding of P-glycoprotein (P-GP)-
mediated pharmacokinetic interactions. In addition, its role in modifying the bioavailability of …

Mechanisms of resistance to conventional therapies for osteosarcoma

L Marchandet, M Lallier, C Charrier, M Baud'huin… - Cancers, 2021 - mdpi.com
Simple Summary Osteosarcoma (OS), the most common primary bone tumor, mainly affects
children and adolescents. Unfortunately, in some cases, the absence of response to …

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells

C Chen, JE Chin, K Ueda, DP Clark, I Pastan… - Cell, 1986 - cell.com
-jie Chen: Janice E. Chin: Kazumitsu Ueda, t las P. Clark, t $ Ira Pastan, t el M. Gottesman,?
and lgor B. Roninson” er for Genetics Iversity of Illinois College of Medicine at Chicago …

A tailored DNA nanoplatform for synergistic RNAi‐/chemotherapy of multidrug‐resistant tumors

J Liu, L Song, S Liu, S Zhao, Q Jiang… - Angewandte Chemie …, 2018 - Wiley Online Library
Multidrug resistance (MDR) is a major obstacle in the clinical treatment of cancer. Herein, a
facile strategy is reported to construct a versatile DNA nanostructure as a co‐delivery vector …

5-Ene-4-thiazolidinones–An efficient tool in medicinal chemistry

D Kaminskyy, A Kryshchyshyn, R Lesyk - European journal of medicinal …, 2017 - Elsevier
The presented review is an attempt to summarize a huge volume of data on 5-ene-4-
thiazolidinones being a widely studied class of small molecules used in modern organic and …